Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy [Phase 3]
A Phase 3 trial evaluating Biphasic Insulin Aspart 30 in Type 2 diabetes patients failing oral therapy has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins
This completed clinical trial assessed glycemic control and quality of care in patients with type 2 diabetes previously treated with Mixtard…
-
CLINICAL_TRIALS research · 2017-01-09Clinical Trial Update: Physiological Concept of Insulin Therapy in Subjects With Type 2 Diabetes
An update on a completed clinical trial exploring the physiological concept of insulin therapy in adults with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes
Observational study evaluating the real-world use of NovoMix 30 and Levemir for Type 1 and Type 2 diabetes; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: The Synergy to Control Emergency Department Hyperglycemia Program for Type 2 Diabetes [NA]
This clinical trial update describes results from MedStar Health Research Institute's program to improve control of emergency department hyp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment
An observational study evaluating outcomes in patients with Type 2 diabetes initiating NovoMix 30 insulin; the trial has completed.
-
FDA approval · 2017-01-06FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro from Eli Lilly and Company.
-
FDA approval · 2017-01-06FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly, updating the product's labeling and approval detai…
-
FDA approval · 2017-01-06FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) by Eli Lilly and Company.
-
FDA approval · 2017-01-06FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2017-01-06FDA Approved: HUMALOG KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog KwikPen (insulin lispro) by Eli Lilly.
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes [Phase 3]
This clinical trial update reports on the Phase 3 evaluation of Biphasic Insulin Aspart 30 for improving blood glucose control in adults wit…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes [Phase 3]
A Phase 3 study comparing three-times-daily BIAsp-70 to two-times-daily BIAsp-30 in adults with type 2 diabetes to evaluate efficacy and saf…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 Diabetes [Phase 1]
Phase 1 pharmacokinetic and pharmacodynamic comparison of biphasic insulin aspart 30 and biphasic human insulin 30 in adults with Type 2 dia…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes [Phase 1]
Phase 1 study comparing pharmacodynamics and pharmacokinetics of biphasic insulin aspart 30 with insulin glargine and insulin glulisine in s…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea. [Phase 3]
This Phase 3 trial assesses the effects of biphasic insulin aspart 70/30 versus exenatide in adults with type 2 diabetes not reaching glycem…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes [Phase 4]
Phase 4 study evaluating the effectiveness and safety of Biphasic Insulin Aspart 70/30 in adults with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes [Phase 4]
Phase 4 study evaluating how often hypoglycemia occurs in Type 2 diabetes patients treated with Biphasic Insulin Aspart 30.
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluating a basal-bolus regimen that combines insulin aspart with insulin NPH and a biphasic insulin aspart in type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes [Phase 3]
A Phase 3 trial compared the pharmacodynamics and pharmacokinetics of Biphasic Insulin Aspart 50 versus Biphasic Insulin Aspart 70 in adults…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes [Phase 4]
This Phase 4 trial evaluates the efficacy and safety of biphasic insulin aspart 30 in combination with metformin for type 2 diabetes; result…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe [Phase 1]
This Phase 1 study evaluated the reliability of dosing with NovoLog Mix 70/30 FlexPen compared with vial and syringe in people with Type 2 d…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting or Switching to Biphasic Insulin Aspart 30 Treatment
This is a completed observational safety study assessing Type 2 diabetes patients starting or switching to Biphasic Insulin Aspart 30. The s…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Observational Study of Safety of NovoMix® 30 Treatment for Type 2 Diabetes
This completed observational study evaluated the safety of NovoMix 30 in people with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes [Phase 4]
This update reports the completion of a Phase 4 clinical trial evaluating the efficacy and safety of biphasic insulin aspart 30 in combinati…